Rheumatic Diseases

• 

  Subject Areas on Research

  • 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. 
  • 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. 
  • 2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases. 
  • 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. 
  • A case of lung, eye and brain disease. 
  • A comprehensive guide for managing the reproductive health of patients with vasculitis. 
  • A systematic review of the association of obesity with the outcomes of inflammatory rheumatic diseases. 
  • Abstracts of the American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting. October 16-21 2009. Philadelphia, Pennsylvania, USA. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 4. 
  • American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 5. 
  • Anti-Müllerian hormone: a better marker of ovarian damage from cyclophosphamide. 
  • Antigenicity of a recombinant Ro (SS-A) fusion protein. 
  • Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification. 
  • Antirheumatic medications in pregnancy and breastfeeding. 
  • Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases: Considerations and Future Directions. 
  • Association of Traditional Chinese Medicine Use With Adherence to Prescribed Western Rheumatic Medications Among Chinese American Patients: A Cross-Sectional Survey. 
  • Associations, populations, and the truth: recommendations for genetic association studies in Arthritis & Rheumatism. 
  • Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. 
  • Autologous stem cell transplantation for pediatric rheumatic diseases. 
  • Biomarkers in rheumatologic disease: a review. 
  • Biosimilars in rheumatology: understanding the rigor of their development. 
  • Bone metabolism in childhood rheumatic disease. 
  • Breastfeeding in women with rheumatic diseases. 
  • CARRA: The Childhood Arthritis and Rheumatology Research Alliance. 
  • COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance. 
  • Cardiovascular Health in Pediatric Rheumatologic Diseases. 
  • Chemerin-activated functions of CMKLR1 are regulated by G protein-coupled receptor kinase 6 (GRK6) and β-arrestin 2 in inflammatory macrophages. 
  • Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatology. 
  • Complementary and alternative medicine for rheumatic diseases: A systematic review of randomized controlled trials. 
  • Compliance and persistence with osteoporosis therapies. 
  • Contraception Use Among Reproductive-Age Women With Rheumatic Diseases. 
  • DNA microarrays: boundless technology or bound by technology? Guidelines for studies using microarray technology. 
  • Decreasing patient cost and travel time through pediatric rheumatology telemedicine visits. 
  • Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders. 
  • Developing an OMERACT Core Outcome Set for Assessing Safety Components in Rheumatology Trials: The OMERACT Safety Working Group. 
  • Dr. Balevic, et al reply. 
  • Exploring the Preferences of Women Regarding Sexual and Reproductive Health Care in the Context of Rheumatology: A Qualitative Study. 
  • Exploring the generalist-subspecialist interface in internal medicine. 
  • Family Planning Counseling for Women With Rheumatic Diseases. 
  • Family pain history predicts child health status in children with chronic rheumatic disease. 
  • Family planning and pregnancy issues for women with systemic inflammatory diseases: patient and physician perspectives. 
  • Fibroblastic rheumatism: a report of 4 cases with potential therapeutic implications. 
  • Fine tuning of immunometabolism for the treatment of rheumatic diseases. 
  • HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. 
  • High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease. 
  • Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy. 
  • Hopefulness of 'Hope'. 
  • Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology Trials. 
  • Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases. 
  • Improving the Safety of Teratogen Prescribing Practices in a Pediatric Rheumatology Clinic. 
  • In vitro RNA selection of an autoimmune epitope on stem-loop II of U1 RNA. 
  • Individual differences in the day-to-day variability of pain, fatigue, and well-being in patients with rheumatic disease: associations with psychological variables. 
  • Infliximab treatment for rheumatic disease: clinical and radiological efficacy. 
  • Introduction to the Special Theme Issue: Heath Disparities and Health Equity in the Rheumatic Diseases. 
  • Introduction to the Special Theme Section: Rehabilitation Sciences and the Rheumatic Diseases. 
  • Is Traditional Chinese Medicine Use Associated with Worse Patient-reported Outcomes among Chinese American Rheumatology Patients? 
  • Managing contraception and pregnancy in the rheumatologic diseases. 
  • Mechanisms of Disease: the role of high-mobility group protein 1 in the pathogenesis of inflammatory arthritis. 
  • Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors. 
  • Mechanisms of inflammation and leukocyte chemotaxis in the rheumatic diseases. 
  • Microchimerism in children with rheumatic disorders: what does it mean? 
  • Microparticles as mediators and biomarkers of rheumatic disease. 
  • Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. 
  • Mind the Gap: Improving Care in Pediatric-to-Adult Rheumatology Transition Through Education. 
  • Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study. 
  • Minimum information about a microarray experiment: comment on the editorial by Firestein and Pisetsky. 
  • Nanoparticle-based diagnostic imaging of inflammation in rheumatic disease. 
  • Nanoscience advances in rheumatology and immunology. 
  • Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status. 
  • Of mice, men and microbes: the impact of the microbiome on immune responses. 
  • Optimization of pediatric rheumatology therapeutics. 
  • Optimizing reproductive health management in lupus and Sjogren's syndrome. 
  • Pain management in rheumatology research, training, and practice. 
  • Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases. 
  • Pediatric Rheumatology Comes of Age: Part I. 
  • Pediatric Rheumatology Comes of Age: Part II. 
  • Pediatric to Adult Transition Literature: Scoping Review and Rheumatology Research Prioritization Survey Results. 
  • Perspectives about complementary and alternative medicine in rheumatology. 
  • Perspectives of Adult Rheumatologists Regarding Family Planning Counseling and Care: A Qualitative Study. 
  • Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy. 
  • Pharmacogenomics in pediatric rheumatology. 
  • Pharmacokinetics of Hydroxychloroquine in Pregnancies with Rheumatic Diseases. 
  • Precision Medicine: Towards Individualized Dosing in Pediatric Rheumatology. 
  • Preconception Counseling. 
  • Pregnancy Outcomes After Exposure to Certolizumab Pegol: Updated Results From a Pharmacovigilance Safety Database. 
  • Progress in intra-articular therapy. 
  • Pulmonary Manifestations of Rheumatic Diseases in Children. 
  • Pulmonary complications of childhood rheumatic disease. 
  • Reduced expression of TRIM21/Ro52 predicts poor prognosis in diffuse large B-cell lymphoma patients with and without rheumatic disease. 
  • Reproductive health needs of adolescent and young adult women with pediatric rheumatic diseases. 
  • Rheumatologic manifestations of cancer. 
  • Rheumatology in 2006: crossroads or crisis? 
  • Rheumatology patients' use of complementary therapies: results from a one-year longitudinal study. 
  • Size matters--nanotechnology and therapeutics in rheumatology and immunology. 
  • State of the art: Reproduction and pregnancy in rheumatic diseases. 
  • Talking with patients about alternative and complementary medicine. 
  • Temporal trends in maternal medical conditions and stillbirth. 
  • The 1978 annual meeting of the American Rheumatism Association. 
  • The Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans: Toward Comparative Effectiveness in the Pediatric Rheumatic Diseases. 
  • The Choosing Wisely initiative: does it have your back? 
  • The management of rheumatic diseases in pregnancy. 
  • The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. 
  • The new FDA labeling rule: impact on prescribing rheumatological medications during pregnancy. 
  • The role of microparticles in the pathogenesis of rheumatic diseases. 
  • The use of analgesics in the management of pain in rheumatic diseases. 
  • Toward Ensuring Health Equity: Readability and Cultural Equivalence of OMERACT Patient-reported Outcome Measures. 
  • Transitioning to Adulthood with a Rheumatic Disease: A Case-Based Approach for Rheumatology Care Teams. 
  • Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases. 
  • Unintended Consequences of SCOTUS Abortion Decision for Patients With Rheumatic Diseases. 
  • Use of Administrative Databases to Assess Reproductive Health Issues in Rheumatic Diseases. 
  • Using registries to identify adverse events in rheumatic diseases. 
• 

  Keywords of People

  • Carnago, Lisa, Student, School of Nursing
  • Grambow, Steven C., Associate Professor of Biostatistics & Bioinformatics, Biostatistics & Bioinformatics